For Immediate Release DIMERIX QUARTERLY ACTIVITIES REPORT Highlights and Operational Activities • Dimerix executed a fifth licensing agreement with Everest Medicines for Greater China, South Korea and Southeast Asia with Dimerix eligible to receive up to approximately A$481...